29 results
Thumbnail

D1.216 - From Acetaminophen to sauerkraut

Thumbnail

D1.217 - Rapid drug desensitization in children: case report

Thumbnail

D1.219 - Impact of a Penicillin Allergy Delabeling Program on Antibiotic Selection and Perioperative Outcomes: A Prospective Comparative Cohort Study

Thumbnail

D1.222 - Comparative analysis and evaluation of clinical and stewardship implications of parent reported antibiotic allergy labels within paediatric care

Thumbnail

D1.223 - Evaluation of Immediate-Type Allergic Reactions to Amide Group Local Anesthetics In Children: A Single-Center

Thumbnail

D1.224 - Clinical performance of IgE Quaternary Ammoniums, Atracurium, Rocuronium and Suxamethonium for the diagnosis of an allergy to curares

Thumbnail

D1.225 - Direct single dose mass delabelling of antibiotic allergy in paediatrics

Thumbnail

D1.226 - Increased incidence of suspected clindamycin hypersensitivity reactions in pediatric patients due to its expanded use in clinical practice

Thumbnail

D1.227 - Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

Thumbnail

D1.228 - Patch testing and HLA genotyping as diagnostic tools for DRESS related to concomitant multidrug exposure

Thumbnail

D1.229 - Limited interest of suxamethonium, rocuronium and atracurium specific IgE reagents for the diagnosis of NMBA allergy sensitization

Thumbnail

D1.230 - Acute Localized Exanthemathous pustulosis induced by Pertuzumab and Trastuzumab with positive Lymphocyte Transformation test

Thumbnail

D1.231 - When Antihistamines Paradoxically Worsen Chronic Spontaneous Urticaria: Trust Your Patient

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series